Clorox (NYSE:CLX) Upgraded at Wall Street Zen

Posted by George Bondi on Nov 10th, 2026

Wall Street Zen upgraded shares of Clorox (NYSE:CLX – Free Report) from a sell rating to a hold rating in a report released on Saturday morning,Wall Street Zen reports.

Other equities research analysts have also recently issued reports about the stock. Evercore upgraded shares of Clorox from an “underperform” rating to a “hold” rating and set a $99.00 price objective on the stock in a research note on Monday, November 2nd. Cantor Fitzgerald reiterated an “overweight” rating on shares of Clorox in a research report on Tuesday, November 3rd. Morgan Stanley increased their target price on shares of Clorox from $87.00 to $94.00 and gave the company an “equal weight” rating in a research report on Wednesday, November 4th. Jefferies Financial Group cut shares of Clorox from a “buy” rating to a “hold” rating and lowered their target price for the company from $125.00 to $98.00 in a research note on Tuesday, July 28th. Finally, TD Cowen restated a “hold” rating on shares of Clorox in a research report on Tuesday, November 3rd. One analyst has rated the stock with a Buy rating, eleven have given a Hold rating and four have given a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of “Reduce” and a consensus price target of $93.79.

Get Our Latest Stock Analysis on Clorox

Clorox Stock Performance

Shares of CLX stock opened at $105.29 on Friday. Clorox has a 12-month low of $79.12 and a 12-month high of $128.90. The company has a debt-to-equity ratio of 32.91, a current ratio of 0.65 and a quick ratio of 0.38. The firm has a market capitalization of $12.76 billion, a price-to-earnings ratio of 15.89, a price-to-earnings-growth ratio of 3.22 and a beta of 0.59. The business has a 50 day simple moving average of $87.77 and a 200 day simple moving average of $99.64.

Clorox (NYSE:CLX – Get Free Report) last announced its earnings results on Monday, November 2nd. The company reported $1.55 earnings per share for the quarter, beating the consensus estimate of $1.07 by $0.48. Clorox had a return on equity of 608.30% and a net margin of 9.41%. The firm had revenue of $1.91 billion for the quarter, compared to the consensus estimate of $1.88 billion. During the same quarter in the previous year, the business earned $0.85 EPS. The firm’s revenue for the quarter was up 33.3% on a year-over-year basis. On average, equities research analysts anticipate that Clorox will post 5.75 EPS for the current year.

Clorox Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Wednesday, October 28th will be issued a $1.25 dividend. The ex-dividend date of this dividend is Wednesday, October 28th. This represents a $5.00 annualized dividend and a dividend yield of 4.7%. Clorox’s dividend payout ratio is currently 89.93%.

Insider Activity at Clorox

In related news, Director Pierre Breber acquired 4,000 shares of Clorox stock in a transaction dated Wednesday, November 4th. The stock was acquired at an average cost of $100.06 per share, with a total value of $400,240.00. Following the purchase, the director directly owned 22,000 shares in the company, valued at $2,201,320. The trade was a 22.22% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 0.51% of the company’s stock.

Institutional Investors Weigh In On Clorox

Several hedge funds have recently modified their holdings of CLX. Carlson Capital L.P. increased its stake in Clorox by 53.6% in the 3rd quarter. Carlson Capital L.P. now owns 133,410 shares of the company’s stock worth $10,808,000 after purchasing an additional 46,555 shares in the last quarter. Royce & Associates LP raised its holdings in Clorox by 85.7% during the 3rd quarter. Royce & Associates LP now owns 7,387 shares of the company’s stock worth $598,000 after buying an additional 3,409 shares during the period. IFG Advisory LLC raised its holdings in Clorox by 3.6% during the 3rd quarter. IFG Advisory LLC now owns 27,732 shares of the company’s stock worth $2,247,000 after buying an additional 965 shares during the period. Diversified Trust Co purchased a new stake in Clorox during the third quarter valued at about $4,122,000. Finally, Moors & Cabot Inc. purchased a new stake in Clorox during the third quarter valued at about $340,000. 78.53% of the stock is owned by hedge funds and other institutional investors.

Clorox Company Profile

(Get Free Report)

The Clorox Company is a consumer products company founded in 1913 and headquartered in Oakland, California. It makes and markets products for household cleaning, food, water filtration, personal care and pet care.

Its portfolio includes Clorox disinfecting and cleaning products, Glad trash bags and food-storage products, Kingsford charcoal, Brita water filters, Hidden Valley dressings and sauces, Burt’s Bees personal-care products, and Fresh Step cat litter. The company also sells products under brands such as Pine-Sol and Liquid-Plumr.

Clorox serves consumers primarily in the United States and also sells products in international markets.